Drug Profile
Artefenomel/ferroquine - Sanofi/Medicines for Malaria Venture
Alternative Names: Ferroquine/artefenomel; Ferroquine/OZ439; OZ439/ferroquineLatest Information Update: 18 Aug 2021
Price :
$50
*
At a glance
- Originator Medicines for Malaria Venture
- Developer Medicines for Malaria Venture; Sanofi
- Class Adamantanes; Aminoquinolines; Antimalarials; Cyclohexanes; Ferrous compounds; Morpholines; Peroxides; Small molecules
- Mechanism of Action Hemozoin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Falciparum malaria; Malaria
Most Recent Events
- 18 Aug 2021 Chemical structure information added
- 24 Mar 2021 Medicines for Malaria Venture plans a phase IIb trial in Malaria (Medicines for Malaria Venture pipeline, March 2021)
- 24 Mar 2021 Medicines for Malaria Venture plans to initiate phase I combination safety in Malaria (Medicines for Malaria Venture pipeline, March 2021)